Subscribe to RSS
DOI: 10.1055/a-1396-4182
Endobiliary radiofrequency ablation for ingrowth occlusion after bilateral metal stent placement in patients with malignant hilar biliary obstruction
Endobiliary radiofrequency ablation (RFA) can prolong the patency of bilateral metal stents (MS) in patients with malignant hilar biliary obstruction [1]. In addition, RFA is a potential treatment option for stent occlusion caused by ingrowth after MS placement [2]. However, there is no evidence of the feasibility of RFA in treating ingrowth after bilateral placement and the safety of repeated RFA remains unknown. Here, we describe a patient who underwent RFA reintervention for ingrowth occlusion after bilateral stent-by-stent (SBS) MS placement with RFA.
An 84-year-old woman with unresectable cholangiocarcinoma had undergone bilateral SBS placement using an uncovered MS (ZeoStent V, Zeon Medical, Tokyo, Japan), following RFA to the left and right hepatic duct strictures using Habib EndoHPB Catheter (Boston Scientific, Marlborough, Massachusetts, United States) and VIO300 D generator (ERBE Elektromedizin GmbH, Tubingen, Germany). Six months after the procedure, obstructive jaundice recurred due to stent occlusion; thus, we performed endoscopic reintervention. After biliary cannulation, two guidewires were advanced into the left and right intrahepatic bile ducts through each MS. A cholangioscope (SpyGlass DS; Boston Scientific) was subsequently inserted over the guidewire, and the cause of occlusion was determined to be an ingrowth in the hilar region. We then performed RFA to the ingrowth within each MS for 90 s at 7 W. Tissue debris was retrieved using a balloon catheter, and the stent lumen was successfully recanalized ( [Fig.1] and [Video 1]). The patient’s symptoms improved without adverse events, and the stents were patent during the follow-up period.
Video 1 Endobiliary radiofrequency ablation for ingrowth occlusion after bilateral stent-by-stent placement in a patient with malignant hilar biliary obstruction.
Quality:
Conclusions
The management of stent occlusion after bilateral MS placement has not been established. Endobiliary RFA may be a useful option when treating ingrowth occlusion, especially after SBS placement.
#
#
Competing interests
Dr. Inoue received honoraria from Boston Scientific Japan and Japan Lifeline Co., Ltd, outside the submitted work.
The other authors disclose no financial relationships relevant to this publication.
-
References
- 1 Inoue T, Ibusuki M, Kitano R. et al. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy 2020; 52: 595-599
- 2 Kadayifci A, Atar M, Forcione DG. et al. Radiofrequency ablation for the management of occluded biliary metal stents. Endoscopy 2016; 48: 1096-1101
Corresponding author
Publication History
Article published online:
27 May 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Inoue T, Ibusuki M, Kitano R. et al. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy 2020; 52: 595-599
- 2 Kadayifci A, Atar M, Forcione DG. et al. Radiofrequency ablation for the management of occluded biliary metal stents. Endoscopy 2016; 48: 1096-1101